Search Results 461-470 of 9308 for Mediate

  1. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  2. Integrative medicine - Doctors & Departments - Mayo Clinic

    This type of medicine adds complementary and alternative medicine (CAM) practices to mainstream medicine.

  3. Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma - Mayo Clinic

    ... mediated Adverse Events (imAEs), as described in the protocol 3. History of non-infectious pneumonitis within the last 5 years 4. TL (lesion planned for ...

  4. Publications - Ayse Tuba Kendi, M.D. - Mayo Clinic

    The A20/TNFAIP3-CDC20-CASP1 Axis Promotes Inflammation-mediated Metastatic Disease in Triple-negative Breast Cancer. Anticancer Res. 2022 Feb; 42(2):681-695.

  5. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  6. Atopic Dermatitis (Eczema) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to create a research registry of patients with Immune-Mediated Inflammatory Skin Conditions (IMISC) within academic and community, ...

  7. Open-Label Study of PEGPH20 With CIS and GEM; PEGPH20 With Atezolizumab, CIS and GEM; and Compared With CIS and GEM Alone in HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma - Mayo Clinic

    Or known cases of hepatobiliary diseases (e.g., primary biliary cholangitis, primary sclerosing cholangitis, history of immune-mediated cholangitis).

  8. Publications - Naveen L. Pereira, M.D. - Mayo Clinic

    Age at onset and clinical course of RBM20-mediated cardiomyopathy. Sci Rep. 2025 Mar 28; 15 (1):10716. View PubMed; Fazzini L, Casula M, Cau R, Figueiral M ...

  9. Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer - Mayo Clinic

    About this study. We are studying whether men being treated for prostate cancer have the same amount of side effects from either one of two different ...

  10. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...